Stay updated on Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial

Sign up to get notified when there's something new on the Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025, and the revision number has changed from v2.16.3 to v2.16.4.
    Difference
    1%
    Check dated 2025-06-20T05:48:18.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.1%
    Check dated 2025-06-13T01:03:14.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.2, indicating a revision in the content. However, there are no significant changes to core content, names, pricing, or availability.
    Difference
    0.4%
    Check dated 2025-06-05T21:14:28.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T16:20:41.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T03:47:11.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The page has undergone significant content removal, including detailed information about a clinical study on risankizumab for psoriasis, while a new version number has been added.
    Difference
    12%
    Check dated 2025-04-23T19:05:18.000Z thumbnail image

Stay in the know with updates to Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial page.